PDK1 and neoplasm: These JX06-NPs circulate in the blood, accumulate at tumor sites, and release JX06 to inhibit PDK1, while metformin, administered orally, regulates glucose levels and inhibits mitochondrial complex I to suppress OXPHOS in tumor cells.